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Purpose: Functional Electrical Stimulation (FES), for dropped foot, has been shown 
to have positive benefits in chronic stroke. It has been suggested similar benefits 
may be seen earlier after stroke. The aim of this feasibility study was to evaluate the 
trial methodology of undertaking a randomised controlled trial (RCT) of FES in sub-
acute stroke.  
 
Method: This was a randomised feasibility study with non-blinded outcomes at six 
and twelve weeks. Sixteen sub-acute stroke in-patients with dropped foot were 
randomised into two groups (Control n=7; Intervention n=9). Both groups received 
routine gait re-education and an orthotic device, the control group used an ankle foot 
orthosis and the intervention group used FES. Outcome measures included gait 
velocity and cadence, Functional Ambulation Classification, Visual Analogue Scale of 
perception of walking and the Stroke Impact Scale.  
 
Results: Eligibility criteria developed for inclusion of participants in the trial were 
appropriate.  Set-up of FES during sub-acute stroke was feasible but more 
challenging than with chronic patients. Outcome measures were suitable and have 
informed the choice of measures for future work.  
 
Conclusions: It is feasible to undertake a trial evaluating FES during the sub-acute 








The annual global incidence of first ever stroke is estimated at 16 million [Strong, 
Mathers and Bonita, 2007]. Dropped foot, defined as the inability to elicit dorsiflexion 
during the swing phase of gait, occurs in about a fifth of the population with 
hemispheric stroke [Verdie et al, 2004; Laufer, Hausdorff and Ring, 2009 ;NICE, 
2009].  
 
One modality available for the management of dropped foot after stroke is functional 
electrical stimulation (FES). FES produces contractions in muscles paralysed due to 
central nervous system lesions by means of electrical stimulation to the peripheral 
nerve. This stimulation produces a functional movement for example activating 
dorsiflexors during the swing phase of walking [Kottink et al, 2007].  
 
Evidence has emerged in recent years about the efficacy of FES in chronic stroke 
patients (>6 months post stroke) [Taylor et al, 1999a; Taylor et al, 1999b; Burridge, 
2001; Penta et al, 2001; Kottink et al, 2004; Robbins, Houghton, Woodbury and 
Brown, 2006 ; Laufer, Hausdorff and Ring, 2009; NICE, 2009; Roche, Laighin and 
Coote, 2009; States, Salem, Pappas, 2009]. This evidence base has reported the 
positive benefits of FES including; reduction in energy expenditure, increased gait 
velocity, decreased falls and improved quality of life.  
 
A number of authors [Granat et al, 1996; Robbins, Houghton, Woodbury and Brown, 
2006; Roche, Laighin and Coote, 2009] have hypothesised that the benefits of FES, 
demonstrated in chronic stroke populations, may be replicated in the early phase of 
recovery after stroke. Granat et al, 1996, proposed that the application of FES in the 
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more acute setting may prevent abnormal gait problems becoming established in the 
longer term. Other potential benefits of applying FES early after stroke may include 
an ability to walk earlier, increased functional independence, earlier discharge home 
and improved motor recovery which may reduce the requirement for long-term use of 
FES or any orthotic device . (Taylor et al, 1999a; Yan, Hui-Chan and Li, 2005). 
Possible secondary benefits may include an increase in confidence, general fitness 
and quality of life (Taylor et al, 1999a). These benefits could reduce the economic 
burden of stroke.  However, to date, there has been very limited research evaluating 
the impact of FES immediately after stroke. This lack of research may be linked to 
the complexity of applying FES during the early stages after stroke or the difficulty of 
assessing its impact beyond that of routine recovery [Wade, 2009]. At present; only 
two studies have investigated the application of FES in acute stroke populations (< 2 
weeks post stroke) [Kottink et al, 2004; Yan, Hui-Chan and Li, 2005; NICE 2008; 
Dunning et al, 2009] with no studies exclusively investigating FES during the sub-
acute phase of stroke (two weeks to six months post stroke) [Kottink et al, 2004].    
 
Yan, Hui-Chan and Li, 2005, undertook a trial with 46 participants, on average 10 
days after stroke. Measures included the composite spasticity scale, ankle 
dorsiflexion torque and the percentage of participants able to walk.  The results 
indicated that motor and walking ability was improved in the FES group.  However, 
there was wide variability of outcome measure scores, a small sample size, short 
duration and non-functional application of FES. Dunning et al in 2009 reported two 
case studies of stroke patients to whom a peroneal FES device was applied less than 
two weeks after stroke. In contrast to Yan et al, the FES was applied in a functional 
context, during walking. Immediate improvements in function (timed up and go) and 
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gait speed (5 metre walk test) were measured in both participants. Further research 
is required in this acute stage after stroke. 
 
Only a small number of studies have investigated the use of FES in sub-acute stroke 
patients, however these have been in combination with patients in a chronic phase 
[Bogataj et al, 1995; Granat et al, 1996; Sheffler, Hennessey, Naples and Chae, 
2007]. One study, [Sheffler, Hennessey, Naples and Chae, 2007] included a sub-
acute case study, but limited information was reported other than that following a 
period of FES the participant could ambulate without an AFO and had no adverse 
side effects.  With no sub-analysis undertaken in the other studies [Bogataj et al, 
1995; Granat et al, 1996] it is not possible to assess the impact of FES during the 
sub-acute phase of stroke. Work is required to investigate FES in sub-acute stroke 
populations.  
 
The Medical Research Council publication ‘Developing and implementing complex 
interventions: new guidance’ [MRC, 2008] highlights the importance of adequate 
development and piloting of interventions, including practical issues, prior to testing in 
larger trials. This phase 1 feasibility study aimed to test the trial methodology when 
investigating FES during the sub-acute phase of stroke in preparation for a larger 
RCT. The key aims of this study were: 
• To define the eligibility criteria of patients recruited to inform future trials.  
• To identify any issues around the application of FES during the sub-acute in-
patient phase of stroke. 
• To collect outcome measures to inform future primary and secondary 






This was a randomised feasibility study with non-blinded outcomes.  
 
Participants and recruitment 
Ethical approval was sought and granted from the Lothian Research Ethics 
Committee. Patients admitted to the stroke rehabilitation unit at Astley Ainslie 
Hospital, Edinburgh and who fulfilled the inclusion and exclusion criteria, were 
approached and invited to participate by the clinical physiotherapist (JS). If patients 
wished to participate their written informed consent was sought prior to 
commencement of the study. 
 
Eligibility criteria were developed by the research team (JS; LS) and were based on 
the literature and clinical experience in application of FES on a chronic stroke 
population. Criteria for inclusion in the study were (i) primary diagnosis of stroke; (ii) 
within four months of stroke; (iii) single dropped foot on side of hemiplegia; (iv) good 
skin condition; (v) no gross oedema of the lower limb; (vi) able to follow simple 
instructions; (vii) commenced assisted walking (able to walk a minimum of five 
metres’ with moderate help of two or walking independently); (viii) able to give 
informed consent; (xi) medically stable. Exclusion criteria were: (i) single dropped foot 
due to lower motor neuron lesion; (ii) high tone in the calf and unable to achieve 
neutral passive dorsiflexion; (iii) pacemaker; (iv) uncontrolled epilepsy; (v) pregnancy; 






Patients were allocated into either a control or intervention group using a computer 
generated simple randomisation list, no stratification was used. The computer 
generated randomisation list was created by a statistician, placed in consecutive 
numbered sealed opaque envelopes and held by the research physiotherapist (LS). 





The control group received routine gait re-education as part of physiotherapy (5 days 
per week for approximately 20 minutes). This included; balance re-education, 
facilitation of lower limb control, strengthening exercises and the provision of walking 
aids as required. An off the shelf ankle foot orthosis (AFO) was provided to correct 
the dropped foot during routine gait re-education. When participants were able to 
mobilise in physiotherapy with supervision; but no physical contact, safely and 
consistently, the AFO was provided to the patient to allow ongoing gait practice with 
the nursing staff in the ward environment. Patients who were independently mobile 
used an AFO to facilitate their gait as required throughout the day.  
Intervention Group  
The intervention group received the same routine gait re-education as the control 
group (5 days per week for approximately 20 minutes). FES was applied as an 
orthotic device for the correction of dropped foot during routine gait re-education.  
The FES device applied was the single channel Odstock Drop Foot Stimulator 
(ODFS) (Odstock Medical Limited, Salisbury, UK; NDI Medical, Cleveland, USA). The 
ODFS is a common peroneal nerve stimulator. Stimulation was provided via skin 
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surface electrodes and triggered by a pressure sensitive foot-switch worn inside the 
shoe and attached to the ODFS box. Within the stimulator box are specific 
parameters that are adjusted, by a trained professional, to suit the individuals gait 
pattern such as current amplitude, ramps and length of stimulation. In this study FES 
application was carried out by the study physiotherapist (JS), trained in the 
application of the ODFS. The stimulator was used during gait practice in 
physiotherapy. When the patient achieved the ability to walk with supervision, but no 
physical contact, safely and consistently in physiotherapy FES was provided to the 
patient to allow ongoing gait practice with the nursing staff in the ward environment. 
Patients who were independently mobile used FES to facilitate their gait as required 
throughout the day.  
 
Outcome Measures 
Outcome measures were collected within three specified components of the World 
Health Organisation International classification of Functioning, Disability and Health 
being Impairment, Activity and Participation. Outcome measures included a battery of 
standardised, published, validated measures to encompass the areas of interest 
including; a timed 10 metre walk test, which tested gait velocity and cadence [Mudge 
and Stott, 2007]; Functional Ambulatory Classification (FAC) on a scale of one to six 
measuring mobility independence [Holden et al, 1984; Holden, Gill and Magliozzi, 
1986]; Stroke Impact Scale (SIS) measuring participation [Duncan et al, 1999] and a 
Visual Analogue Scale (VAS) measuring patients’ perception of change in walking.  
 
Gait velocity and cadence were measured using a timed 10 metre walk with a 
stopwatch to time and the number of steps counted over the same distance. Patients 
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walked at a self-selected pace using walking aids as required but with no physical 
assistance. It has previously been demonstrated that these measures are valid and 
reliable for use within stroke populations [Mudge and Stott, 2007]. The FAC classifies 
the level of ambulation into six categories. Scores of one to three indicate the need 
for physical assistance during ambulation, a score of four requires supervision only 
during walking, while a score of five or six represents two different levels of 
independent walking [Holden, Gill and Magliozzi, 1986]. Inter-rater reliability for the 
FAC has been established [Holden et al, 1984] although other aspects of validity and 
reliability have not been reported. The SIS is a stroke specific outcome measure 
developed to capture different dimensions of health-related quality of life in individual 
domains. These domains include strength, memory, emotions, communication, 
activities, mobility, hand function and participation. A composite recovery score is 
also calculated. Reliability, validity and sensitivity to change has been established 
and changes of approximately 10 to 15 points are deemed clinically meaningful. 
[Duncan et al, 1999]. The VAS of their perception of change in walking was an un-
validated VAS five point scale encompassing much worse, slightly worse, no change, 
slightly better and much better. The validity and reliability of VAS in stroke 
populations is poor and their use questionable [Price, Curless and Rodgers, 1999], 
however the VAS was included in this study as a gross indicator of the patient’s 
perception of walking. 
 
All outcome measures with the exception of the VAS were collected at baseline prior 
to randomisation. The full battery of outcomes were assessed at six and twelve 
weeks post randomisation. All data collection was undertaken by the study 





Descriptive statistics were used to summarise baseline data. Median and inter-
quartile ranges are reported as testing revealed non-normal distribution for the 
majority of the data. To test for statistical differences between the groups a Mann-
Whitney U test was used. An intention to treat analysis was undertaken.  
 
RESULTS 
Potential participants were recruited between August 2006 & April 2007and February 
2008 & August 2008. Recruitment was suspended between May 2007 and January 
2008 due to unforeseen staff absence and the commencement of an additional 
rehabilitation trial within the unit that led to potential participants being recruited into 
this other trial. There were 159 stroke patients admitted to the rehabilitation unit and 
screened for inclusion during the 16 months of active recruitment. In total 16 
participants who met the eligibility criteria were approached for inclusion and all 
consented to participate in this feasibility study. This equated to an overall 
recruitment rate of 10% (16/159) with 100% (16/16) of all those approached 
consenting to be included in the study. Seven participants were randomised to the 
control group and nine to the intervention group. There were two deaths prior to data 
collection at 12 weeks, one from each group. Figure 1 provides a consort diagram.  
 
INSERT FIGURE 1 ABOUT HERE 
 
Table 1 summarises the participant characteristics at the time of entry into the study. 
The two study groups were similar in age, gender, side of hemiparesis and stroke 
11 
 
classification although the time since stroke was greater in the control group. This 
feasibility study had three key aims and the results will address each of these aims in 
turn. 
 
INSERT TABLE 1 ABOUT HERE 
 
Eligibility criteria 
Of the 159 total admissions 143 were ineligible based on the developed criteria.  A 
large proportion of those ineligible did not present with a dropped foot (n=85). Other 
reasons for ineligibility included a short length of stay (n=9); no assisted walking 
(n=9); inability to follow simple instructions (n=13); over 4 months since stroke (n=3); 
high tone (n=1); recruited to another trial (n=4); fragile skin (n=2) and missing data 
(n=17). Of those participants randomised to the intervention group the application of 
FES was unsuccessful for one participant only. This failure was as a result of 
significant tone in the calf, measuring a score of three on the modified Ashworth 
scale [Bohannon and Smith, 1987] measured in supine with the leg extended. 
 
Factors that had affected on-going compliance with the application of FES, during 
this sub-acute phase, included: mood, confidence and the ability to engage with 
technology. Of interest, one participant in the study who met the inclusion/exclusion 
criteria and was allocated to the control group failed to achieve independent walking 
and was subsequently wheelchair bound.  
 




In this study FES was set-up by the clinical physiotherapist (JS) who had training and 
extensive experience of FES set-up in a chronic stroke population. In contrast to 
application of FES during the chronic phase it was found that during this sub-acute 
phase the set-up required regular adjustment and modification to accommodate for 
the fluctuating physical status. No adverse events occurred. 
 
To facilitate and ensure compliance with FES outwith physiotherapy in the 
intervention group it was found that ongoing education for both ward-based staff and 
carers was necessary. Education required included set-up of the device; electrode 
and skin care; device maintenance and simple problem solving strategies in the 
event of stimulation failure.  
 
Outcome Measures 
The results of outcomes measured are reported in tables two and three. No 
statistically significant differences were found between groups for any of the outcome 
measures at six and 12 weeks. The rate of follow-up at each time-point was: 94% at 
six weeks (15/16) and 88% at 12 weeks (14/16). However, completion rates of 
individual outcome measures at the different time-points varied from 19% to 100%. 
The CONSORT diagram (figure 1) provides a summary of the numbers completing 
each outcome measure at each time-point. Reasons for non-completion of outcome 
measures included being unable to walk, poor comprehension, refusal to complete, 
fatigue and a lack of time to complete the full battery of outcome measures.  
 




Some participants failed to complete the full battery of outcomes. Only two outcome 
measures had the potential to be completed at all time-points (FAC and SIS) as the 
physical outcomes (gait velocity, gait cadence) could only be measured when 
participants were able to walk independently. The FAC achieved the highest 
completion levels (88%-100%) across the time-points. In contrast, the SIS achieved 
much lower completion rates due to issues such as poor comprehension of the 
participant, refusal to fill it in due to the nature of the questions and time restraints on 
the data collection by the researcher due to the length of the outcome measure.  
 
Intention to treat analysis was carried out as not all participants in the intervention 
group were using FES at the time of outcome measurement. Of the nine participants 
in the intervention group, at six weeks, seven were using FES. By 12 weeks only 
three participants were still using FES to assist with walking. At six weeks, for one 
participant set-up of FES had been unsuccessful due to high tone and one participant 
no longer required the device as they had regained adequate active dorsiflexion. By 
12 weeks one further participant no longer required the device due to recovery of 
active movement, one participant had died and two participants had stopped use due 





Overall, this study explored the feasibility of applying and evaluating FES during the 
sub-acute phase of stroke. The study has provided clarification about eligibility 
criteria and practical issues associated with the clinical application of FES during this 
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sub-acute phase of recovery after stroke. Furthermore, it has informed the choice of 
primary and secondary outcome measures for future studies.  
 
Trial Design 
This study recruited from a stroke rehabilitation unit with an overall average time to 
trial after stroke of 59 days. Targeting recruitment in the rehabilitation hospital only 
may have missed participants discharged directly home from the acute setting. In 
addition it was noted that the age of the population recruited into the study was 
considerably lower than the average age of the 143 participants screened for 
inclusion. In the control group one participant who met the inclusion criteria of 
assisted walking failed to walk independently. Future studies should consider 
recruiting from both acute stroke and rehabilitation units, ensure that older stroke 
populations are included and stratify at baseline by physical ability and age.  
 
Eligibility Criteria 
In this study recruitment rates of 10% of the whole stroke population passing through 
the stroke rehabilitation unit were achieved. It was identified that some patients 
excluded from this study could have been recruited if the eligibility criterion had been 
broadened. For example, if those patients with a short hospital length of stay had 
been provided with an out-patient follow-up service they could have used FES after 
discharge. A number of patients were unable to follow simple instructions, this could 
be addressed with the provision of additional support. For one participant the 
application of FES was unsuccessful due to high tone and it is proposed that in future 
high tone is defined as three or more on the modified Ashworth scale. Factors 
identified that affected on-going compliance with FES included mood, confidence and 
15 
 
the ability to engage with technology. Future studies should consider screening for 
these issues to assess their impact on the use of FES. Roche, Laighin and Coote, 
2009 highlighted the need for further evidence to inform the selection of candidates 
for FES at this stage of recovery and this study contributes further knowledge which 
could be explored in more depth in larger studies.    
 
Application of FES 
In this study differences in set-up of FES between the chronic and sub-acute stroke 
populations were found by the clinical physiotherapist. During the chronic phase of 
physical recovery after stroke a plateau is often reached [Jorgensen, Nakayama, 
Raaschov, and Olsen, 1995] resulting in a relatively unchanging clinical presentation 
of impairments. In contrast, during the earlier phases after stroke, when a physical 
plateau has not been reached, change to impairments such as muscle tone is 
ongoing. As a result the application of FES during the sub-acute phase after stroke 
requires additional monitoring and frequent alterations to the set-up. In a multi-centre 
trial this could be difficult if clinical staff are inexperienced in the application of FES.  
 
During this study FES was used in a functional manner, during walking, both within 
physiotherapy and the ward environment. This is in line with recommendations 
[Kottink et al, 2007; Robbins, Houghton, Woodbury and Brown, 2006] that patients 
should ambulate while using FES to increase the effectiveness of the intervention on 
gait. This study has demonstrated it is feasible to use FES in the sub-acute phase 





In the intervention group it was found that some participants no longer required FES. 
Some authors have highlighted the potential of FES to influence neuroplasticity 
[Burridge and Ladoucer, 2001; Roche, Laighin and Coote, 2009] during the early 
phase of recovery after stroke and these findings warrant the further investigation of 
the therapeutic effect of FES in the sub-acute phase of recovery.  
 
Outcome Measures 
A battery of outcome measures was collected and the study provided valuable 
information for future trial design. The completion rate between outcome measures 
varied. The FAC provided the most complete data-sets while the physical tests of gait 
speed and cadence highlighted some interesting results, particularly with regard to 
the orthotic versus therapeutic effect of FES. In some patients receiving FES there 
appeared to be a carry-over effect on their motor control when FES was removed. 
The use of VAS scores, while achieving reasonable completion in this study, have 
been questioned in stroke research due to issues of validity [Price, Curless and 
Rodgers, 1999].   
 
The high completion rates of the FAC indicate it should be considered as a possible 
primary outcome in future trials. However, it is a relatively crude outcome measure. A 
power calculation (85% power with a 0.05 significance level) undertaken using FAC 
data from this study indicated that 200 participants would be required for each group 
to detect a difference. Applying a more sensitive physical measure may reduce the 
number of participants required. The Rivermead Mobility Index [Collen, Wade, Robb 
and Bradshaw, 1991] was identified as an alternative primary outcome measure for 
consideration in future studies. This measure is more sensitive than the FAC but 
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could still be administered easily in a large trial including by post or over the phone, 
hence increasing follow-up rates. In addition it is valid in both ambulant and non-
ambulant populations. This is in contrast to physical measures which would require 
both the patient to be ambulant and a face to face visit. These physical measures 
should be considered as secondary outcomes. [Forlander and Bohannon, 1999] 
 
Inclusion of measures of quality of life in studies evaluating FES have been 
recommended [Roche, Laighin and Coote, 2009] and the SIS was collected in this 
study.  The SIS can provide detailed information about the impact of the intervention 
on health related quality of life. Although completion of this measure was affected by 
comprehension and the length of time required to complete all sections it would still 
be considered an important secondary measure in future studies. Consideration 
could be given to undertaking a qualitative study in a small sub-group to explore in 
detail participants perceptions of the impact of FES at this early stage.   
 
In this study neither the intervention nor collection of outcome measures was blinded. 
Blinding of the intervention in rehabilitation trials is difficult to achieve [Wade, 2009] 
although in future studies an attempt to blind the collection of outcome measures 
should be made. In addition longer term outcomes should be collected to assess the 
long-term impact of FES for example six and twelve months after randomisation 
 
An interesting finding was the shorter length of stay in the intervention group between 
randomisation and discharge home. In the control group (n=6) the average length of 
stay (median (IQR)) was 121.5 (49-176.5) days compared to 80 (52-115) days in the 
intervention group (n=8). Statistical analysis revealed no statistically significance 
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difference between the groups. This trend should be explored further in future studies 
and combined with an economic analysis.  
 
This study has shown it is feasible to use FES in the sub-acute phase of recovery 
after stroke. Recommendations have been made to the eligibility criteria for patients 
in this phase after stroke. The study has identified and suggested strategies to 
address issues around the application of FES early after stroke. These suggestions 
could be implemented both in future research and clinical practice. The choice of 
primary measure in future studies would be limited by the population under 
investigation. The measure selected would need to reflect this and a simple 
questionnaire related to participants’ level of independent walking may be more 
appropriate. However the importance of secondary measures to evaluate the 
therapeutic and orthotic effect of FES should not be negated. It is recognised that the 
small sample size of this study limits any inferences that can be made about the 




This study has demonstrated the feasibility of applying FES for dropped foot during 
the sub-acute phase of recovery after stroke. No statistically significant differences 
were identified between groups for any outcome measures. However this study only 
had a small sample size. Despite this the experience gained and data collected has 
informed future trial design. A larger randomised controlled trial is required to explore 
the clinical effect of FES, both therapeutic and orthotic, during this sub-acute phase 
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